Welcome to Corona Virus Net
Corona Virus Net is the web resource for anyone interested in Coronaviruses. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (COVID-19) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and humans. Common signs of infection include respiratory symptoms, fever, cough, and shortness of breath. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing. Also avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.
A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO on 31 December 2019. The outbreak of COVID-19 was declared a Public Health Emergency of International Concern on 30 January 2020 by the WHO. As of March 11th, the WHO declared the rapidly spreading coronavirus outbreak a pandemic, acknowledging that the virus will likely spread to all countries in the world.
The objectives of Corona Virus Net are to be the public and professional information resource for coronaviruses and to serve as a network in the exchange of information and news related to coronaviruses. What do you know about the novel Coronavirus that is causing a health emergency?
Coronavirus News and Headlines
- Novavax exec says its new COVID shot should work against variants on the rise - Reuters
Mon, 05 Jun 2023 22:47 GMT - Data shows COVID-19 hospitalizations, severe outcomes continue to decline, but we must remain vigilant: experts - CTV News
Mon, 05 Jun 2023 19:21 GMT - OHSU coronavirus (COVID-19) response - OHSU News
Mon, 05 Jun 2023 19:23 GMT - Took a Coronavirus Withdrawal From Your Retirement Plan in 2020? Time May Be Running Out to Repay It and Save ... - The Motley Fool
Tue, 06 Jun 2023 10:18 GMT - Who should get another COVID-19 vaccine dose? - UC Davis Health
Mon, 05 Jun 2023 19:09 GMT - The Covid deaths that did not get counted - The Guardian
Mon, 05 Jun 2023 16:45 GMT - Hong Kong’s sixth Covid wave has peaked, cases to drop ‘in few more weeks’ - South China Morning Post
Sat, 03 Jun 2023 03:18 GMT - Years of austerity left UK 'hugely unprepared' for COVID pandemic, report says - Sky News
Sun, 04 Jun 2023 23:43 GMT - Study Defines Four Distinct Phenotypes of Long COVID - Inside Precision Medicine
Mon, 05 Jun 2023 14:02 GMT - The universal role of Nsp1: Common mechanisms of translational ... - News-Medical.Net
Tue, 06 Jun 2023 03:51 GMT - Living in a world after the coronavirus - The Riverdale Press
Sun, 04 Jun 2023 04:14 GMT - Top Chinese scientist concedes that coronavirus may have leaked from Wuhan lab - Yahoo News
Thu, 01 Jun 2023 18:17 GMT - Public Health Lessons Learned From the Coronavirus Pandemic - The New York Times
Thu, 11 May 2023 07:00 GMT - Former Connecticut lawmaker gets 27 months in prison for stealing ... - KSLTV
Wed, 31 May 2023 18:09 GMT - India Records 124 New Covid Cases In 24 Hours - NDTV
Tue, 06 Jun 2023 04:55 GMT
Latest Coronavirus Posts on ProMED-mail
- PRO/AH/EDR> COVID-19 update (323): Pfizer vaccine in children, vaccine diplomacy, WHO
Mon, 20 Sep 2021 21:44:10 -0400
COVID-19 -- Worldwide/Unknown
A lower dose of the Pfizer-BioNTech coronavirus vaccine -- one-3rd the amount given to adults and teens -- is safe and triggered a robust immune response in children as young as 5 years old, the drug companies announced in a news release Monday morning.
The finding, eagerly anticipated by many parents and pediatricians, is a crucial step toward the 2-shot coronavirus vaccine regimen becoming available for younger school-aged children, perhaps close to Halloween.
The companies still must
Latest Articles on Coronaviruses
- Gastrointestinal manifestations of long-term effects after COVID-19 infection in patients with dialysis or kidney transplantation: An observational cohort study Mon, 05 Jun 2023 06:00:00 -0400
CONCLUSION: Different from patients with non-chronic kidney disease, there was a high prevalence of GI manifestations of Long-COVID in dialysis-dependent patients and KT recipients. An appropriate long-term follow-up in these vulnerable populations after COVID-19 infection is possibly necessary. - Neuroimaging mechanisms of acupuncture on functional reorganization for post-stroke motor improvement: a machine learning-based functional magnetic resonance imaging study Mon, 05 Jun 2023 06:00:00 -0400
CONCLUSION: Feature ROIs identified by machine learning can predict the classification of stroke patients with different motor improvements, and the FC between these ROIs with other brain regions is decreased. Acupuncture can modulate the bilateral cerebral hemispheres to restore abnormal FC via different targets, thereby promoting motor recovery after stroke. - Differences in the Cell Type-Specific Toxicity of Diamond Nanoparticles to Endothelial Cells Depending on the Exposure of the Cells to Nanoparticles Mon, 05 Jun 2023 06:00:00 -0400
CONCLUSION: We confirmed the presence of a relationship between the toxicity of diamond nanoparticles and the level of cell exposure to nanoparticles and the nanoparticle surface. The results of the study give new insights into the conditioned toxicity of nanomaterials and their use in biomedical applications. - A Cause of Heart Failure: Corona-Cameral Fistula Mon, 05 Jun 2023 06:00:00 -0400
No abstract - Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care Sun, 04 Jun 2023 06:00:00 -0400
CONCLUSION: Our results suggest that parents of undiagnosed children seeking enrollment in genomic diagnosis research are at risk of a form of therapeutic misconception - in this case, diagnostic misconception. These findings indicate the need to examine the processes and procedures associated with this research in order to appropriately communicate and balance the potential burdens and benefits of study participation. - Instrument-assisted soft tissue mobilization versus myofascial release therapy in treatment of chronic neck pain: a randomized clinical trial Sat, 03 Jun 2023 06:00:00 -0400
CONCLUSION: This study showed insignificant differences between groups. However, we did not use a control group, indicating that the improvement in outcomes may not have been caused by the intervention. - Dual targeting Salinomycin-loaded smart nanomicelles for enhanced accumulation and therapeutic outcome in breast cancer Fri, 02 Jun 2023 06:00:00 -0400
Salinomycin is a polyether compound that exhibits strong anticancer activity and is known as the cancer stem cell inhibitor that reached clinical testing. The rapid elimination of nanoparticles from the bloodstream by the mononuclear phagocyte system (MPS), the liver, and the spleen, accompanied by protein corona (PC) formation, restricts in vivo delivery of nanoparticles in the tumor microenvironment (TME). The DNA aptamer (TA1) that successfully targets the overexpressed CD44 antigen on the... - Body composition and physical activity of university students during COVID-19 lockdowns Fri, 02 Jun 2023 06:00:00 -0400
[Purpose] Behavioral restrictions during the corona virus disease 2019 (COVID-19) pandemic may have affected the physical activity levels of college students. We aimed to characterize the body composition and physical activity of college students during these behavioral restrictions. [Participants and Methods] The body composition (height, weight, body mass index, body fat mass, body fat percentage, total body muscle mass, free-fat muscle index [FFMI], and fat mass index [FMI]), physical... - Cutaneous Adverse Drug Reactions (CADRs) to COVID19 Vaccines: A Case Series Fri, 02 Jun 2023 06:00:00 -0400
Viral vector vaccines (Covishield) and inactivated vaccines (Covaxin) are now being administered worldwide to reduce the impact of life-threatening corona virus disease 19 (COVID-19). Various cutaneous adverse drug reactions (CADRs) have been reported following COVID-19 vaccination. Here, we are reporting series of CADRs following COVID-19 vaccination. Among 18 CADRs, 4 each were of acute urticaria and pityriasis rosea, 2 each of leukocytoclastic vasculitis and herpes zoster, 3 exacerbation of... - Compromised white matter is related to lower cognitive performance in adults with phenylketonuria Fri, 02 Jun 2023 06:00:00 -0400
Despite increasing knowledge about the effects of phenylketonuria on brain structure and function, it is uncertain whether white matter microstructure is affected and if it is linked to patients' metabolic control or cognitive performance. Thus, we quantitatively assessed white matter characteristics in adults with phenylketonuria and assessed their relationship to concurrent brain and blood phenylalanine levels, historical metabolic control and cognitive performance. Diffusion tensor imaging...